🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rituximab will be tested for its safety and potential efficacy in treating ...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2005-06
Trial ID
NCT00697996
Treatments Being Tested
This is a pilot study to determine if extended release Envarsus at an optim...
Status
Terminated
Location
University of Colorado Anschutz Medical Campus
Start Date
2018-01-17
Trial ID
NCT03380936
The aim of the study is to find out if Rituximab, which is an antibody agai...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2004-08
Trial ID
NCT00695097
Treatments Being Tested
This trial evaluates the addition of rituximab to standard of care in the t...
Status
Terminated
Location
Imperial College London
Start Date
2019-07-17
Trial ID
NCT03994783
Treatments Being Tested
In this trial, we aim to improve the outcomes of haplo cord transplant. Hap...
Status
Completed
Location
University of Chicago Medical Center
Start Date
2012-10-16
Trial ID
NCT01810588
The study titled "Daratumumab for Late Antibody-Mediated Rejection in Kidne...
Status
Recruiting
Location
University hospital Martin
Start Date
2025-07-01
Trial ID
NCT07081126
Treatments Being Tested
The best treatment for kidney failure is a kidney transplant, but a transpl...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2020-09-01
Trial ID
NCT04496037
Treatments Being Tested
This study is designed to investigate the efficacy and safety of allogeneic...
Status
Unknown
Location
The First Affiliated Hospital, Sun Yat-sen University
Start Date
2015-11
Trial ID
NCT02563340
Treatments Being Tested
Assessing the impact of J12 curative treatment with rituximab (375 mg / m² ...
Status
Unknown
Location
Hospital Henri Mondor
Start Date
2008-10
Trial ID
NCT01066689
Treatments Being Tested
Primary Objectives: * Cohort A: To evaluate the efficacy of BIVV020 in pre...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center- Site Number : 8400100
Start Date
2022-06-09
Trial ID
NCT05156710